Practice-Based Clinical Research and Ethical Decision Making-Part I: Deciding Whether to Incorporate Practice-Based Research into Your Clinical Practice

ABSTRACT

Calls for increasing clinical research in routine care settings aim to improve the empirical and ethical foundations of evidence-based practice. In the treatment and prevention of stroke many troubling management questions remain uninvestigated by the clinical research enterprise. Many practicing physicians perceive available data as having limited applicability to their average patients. Recent efforts by the National Institute of Neurological Disorders and Stroke seek to establish clinical research networks that will expand the role of private practice physicians in the conduct of research on stroke and other neurological diseases, akin to practice-based research networks supported by the Agency for Healthcare Research and Quality and other National Institutes of Health institutes. Adding clinical research to one's practice of medicine has practical and ethical implications. Furthermore, because of the growth and expansion of clinical research, all practicing physicians should have a fundamental understanding of clinical research and the differences between clinical care and clinical research, even if they are not directly involved in the conduct of clinical research, to appropriately advise their patients. In this and the following article, we offer two practical frameworks to aid physicians contemplating adding clinical research to their everyday practice of medicine.

KEYWORDS

Practice-based research - research networks - ethics - therapeutic misconception - conflicts of interest - conflicts of commitment - systems-informed professionalism - balanced scorecard

REFERENCES

• 1 Broderick J, Brott T, Kothari R et al.. The greater Cincinnati/northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among blacks.  Stroke. 1998;  29 415-421
• 2 Williams G R. Incidence and characteristics of total stroke in the United States.  BMC Neurol. 2001;  1 2
• 3 Kleindorfer D, Panagos P, Pancioli A et al.. Incidence and short-term prognosis of transient ischemic attack in a population-based study.  Stroke. 2005;  36 720-723
• 4 Leary M C, Saver J L. Annual incidence of first silent stroke in the United States: a preliminary estimate.  Cerebrovasc Dis. 2003;  16 280-285
• 5 Johnston S C, Fung L H, Gillum L A et al.. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.  Stroke. 2001;  32 1061-1068
• 6 Katzan I L, Hammer M D, Hixson E D et al.. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.  Arch Neurol. 2004;  61 346-350
• 7 Centers for Disease Control and Prevention (CDC) . Declining prevalence of no known major risk factors for heart disease and stroke among adults-United States, 1991-2001.  MMWR Morb Mortal Wkly Rep. 2004;  53 4-7
• 8 Institute of Medicine .Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC; National Academy Press 2001
• 9 Smedley B D, Stith A Y, Nelson A R. Institute of Medicine. (U.S.) .Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, D.C.; National Academy Press 2003
• 10 Sung N S, Crowley Jr W F, Genel M et al.. Central challenges facing the national clinical research enterprise.  JAMA. 2003;  289 1278-1287
• 11 Tunis S R, Stryer D B, Clancy C M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.  JAMA. 2003;  290 1624-1632
• 12 Sandercock P. What questions can large, simple trials answer?.  Cerebrovasc Dis. 1998;  8(suppl 2) 30-36
• 13 Buring J E, Hennekens C H. The contribution of large, simple trials to prevention research.  Prev Med. 1994;  23 595-598
• 14 Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials.  Ann NY Acad Sci. 1993;  703 314-340
• 15 Nutting P A, Beasley J W, Werner J J. Practice-based research networks answer primary care questions.  JAMA. 1999;  281 686-688
• 16 Nutting P A, Baier M, Werner J J et al.. Practice patterns of family physicians in practice-based research networks: a report from ASPN (ambulatory sentinel practice network).  J Am Board Fam Pract. 1999;  12 278-284
• 17 SWOG .The history and evolution of the Southwest Oncology Group. Available at: http://www.swog.org/Visitors/download/policies/Policy00.pdf Accessed August 3, 2005
• 18 AHRQ .Fact sheet: primary care practice-based research networks. Available at: http://www.ahrq.gov/research/pbrnfact.htm Accessed July 25, 2005
• 19 Lanier D. Primary care practice-based research comes of age in the United States.  Ann Fam Med. 2005;  3 S2-S4
• 20 NIH .Re-engineering the clinical research enterprise. NIH Roadmap Initiative 2005
• 21 Mold J W, Peterson K A. Primary care practice-based research networks: working at the interface between research and quality improvement.  Ann Fam Med. 2005;  3(suppl 1) S12-S20
• 22 Kemmis S, McTaggart R. Participatory action research. In: Denzin NK, Lincoln YS Handbook of Qualitative Research. Thousand Oaks, CA; Sage Publications 2000: 567-606
• 23 NHLBI .Ardsnet clinical network. Available at: http://www.ardsnet.org/ Accessed July 22, 2005
• 24 NCI .Cancer therapy evaluation program. Available at: http://ctep.cancer.gov/resources/coop.html Accessed July 22, 2005
• 25 AHRQ .Centers for education and research on therapeutics. Available at: http://www.ahrq.gov/clinic/certsovr.htm2005 Accessed July 22, 2005
• 26 Lader E W, Cannon C P, Ohman E M et al.. The clinician as investigator: participating in clinical trials in the practice setting.  Circulation. 2004;  109 2672-2679
• 27 Henry K, Lawyer B L. Subcommittee motAMD. Neurologists 2004: AAN member demographics and practice characteristics. 2005: 11-12
• 28 Marler J R. Help wanted: the best and the brightest neurologists to advance neurological treatments.  Neurology Today. 2005;  5 4
• 29 NINDS .NINDS Clinical Research Collaboration Workshop. Bethesda, MD, October 7-8, 2002. http://Available at: www.ninds.nih.gov/news_and_events/proceedings/2002_clinical_research_workshop.htm Accessed December 19, 2005
• 30 NINDS-Stroke-PRG .Report of the stroke progress review group. 2002 3-7 41-49
• 31 NINDS .Proceedings of the Stroke Disparities Advisory Panel Meeting. Bethesda, MD, November 7-8, 2002. http://Available at: www.ninds.nih.gov/news_and_events/proceedings/stroke_report_nov_2002.htm Accessed December 19, 2005
• 32 Kissela B, Schneider A, Kleindorfer D et al.. Stroke in a biracial population: the excess burden of stroke among blacks.  Stroke. 2004;  35 426-431
• 33 White H, Boden-Albala B, Wang C et al.. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the northern Manhattan study.  Circulation. 2005;  111 1327-1331
• 34 NINDS .PAR-05-084: specialized program of translational research in acute stroke. Available at: http://grants.nih.gov/grants.guide/pa-files/PAR-05-084.html Accessed July 17, 2005
• 35 Morin K, Rakatansky H, Riddick Jr F A et al.. Managing conflicts of interest in the conduct of clinical trials.  JAMA. 2002;  287 78-84
• 36 Klein J E, Fleischman A R. The private practicing physician-investigator: ethical implications of clinical research in the office setting.  Hastings Cent Rep. 2002;  32 22-26
• 37 Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry.  N Engl J Med. 2000;  342 1539-1544
• 38 Lightfoot G D, Sanford S M, Shefrin A. Can investigator certification improve the quality of clinical research?.  Qual Manag Health Care. 1999;  7 31-36
• 39 Beach J E. Clinical trials integrity: a CRO perspective.  Account Res. 2001;  8 245-260
• 40 Rettig R A. The industrialization of clinical research.  Health Aff (Millwood). 2000;  19 129-146
• 41 Eichenwald K, Kolata G. Drug trials hide conflicts for doctors. New York Times (print). 1999: 1, 34
• 42 Green L A, White L L, Barry H C, Nease Jr D E, Hudson B L. Infrastructure requirements for practice-based research networks.  Ann Fam Med. 2005;  3(suppl 1) S5-S11
• 43 Pace W D, Staton E W, Holcomb S. Practice-based research network studies in the age of HIPAA.  Ann Fam Med. 2005;  3(suppl 1) S38-S45
• 44 Wolf L E, Walden J F, Lo B. Human subjects issues and IRB review in practice-based research.  Ann Fam Med. 2005;  3(suppl 1) S30-S37
• 45 Wolf L E, Croughan M, Lo B. The challenges of IRB review and human subjects protections in practice-based research.  Med Care. 2002;  40 521-529
• 46 Brody H, Miller F G. The clinician-investigator: unavoidable but manageable tension.  Kennedy Inst Ethics J. 2003;  13 329-346
• 47 Chen D T. Practice-based clinical research and ethical decision-making-part II: deciding whether to host a particular research study in your practice.  Semin Neurol. 2005;  , In press
• 48 Chen D T, Miller F G, Rosenstein D L. Clinical research and the physician-patient relationship.  Ann Intern Med. 2003;  138 669-672
• 49 Fleischman A R, Klein J E. Clinical research in the private office setting: ethical issues.  Trans Am Clin Climatol Assoc. 2002;  113 126-135 discussion 135-126
• 50 Miller F G, Brody H. A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials.  Hastings Cent Rep. 2003;  33 19-28
• 51 Miller F G, Rosenstein D L, DeRenzo E G. Professional integrity in clinical research.  JAMA. 1998;  280 1449-1454
• 52 Eichenwald K, Kolata G. A doctor's drug studies turn into fraud. New York Times (print). 1999: A1, A16
• 53 Werhane P, Doering J. Conflicts of interest and conflicts of commitment.  Prof Ethics. 1995;  4 47-81
• 54 Miller F G, Rosenstein D L. The therapeutic orientation to clinical trials.  N Engl J Med. 2003;  348 1383-1386
• 55 Appelbaum P S, Lidz C W, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors.  IRB. 2004;  26 1-8
• 56 Appelbaum P S, Roth L H, Lidz C W, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception.  Hastings Cent Rep. 1987;  17 20-24
• 57 Dresser R. The ubiquity and utility of the therapeutic misconception.  Soc Philos Policy. 2002;  19 271-294
• 58 Lidz C W, Appelbaum P S. The therapeutic misconception: problems and solutions.  Med Care. 2002;  40 V55-V63
• 59 Casarett D, Karlawish J H, Sugarman J. Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications.  JAMA. 2000;  283 2275-2280
• 60 Casarett D, Karlawish J H, Sugarman J. Should patients in quality-improvement activities have the same protections as participants in research studies?.  JAMA. 2000;  284 1786-1788
• 61 Stimler C. Quality improvement projects: inaction presents the greatest risk.  Arch Intern Med. 2003;  163 2648-2649
• 62 Lynn J. When does quality improvement count as research? Human subject protection and theories of knowledge.  Qual Saf Health Care. 2004;  13 67-70
• 63 Lo B, Groman M. Oversight of quality improvement: focusing on benefits and risks.  Arch Intern Med. 2003;  163 1481-1486
• 64 Bellin E, Dubler N N. The quality improvement-research divide and the need for external oversight.  Am J Public Health. 2001;  91 1512-1517
• 65 Bradley E H, Webster T R, Baker D et al.. Translating research into practice: speeding the adoption of innovative health care programs.  Issue Brief (Commonw Fund). 2004;  (724) 1-12
• 66 Chen D T, Mills A E, Werhane P H. Towards systems-informed professionalism. In: Mills AE, Chen DT, Werhane P, Wynia M Professionalism in Tomorrow's Healthcare System: Towards Fulfilling the ACGME Requirements for Systems-Based Practice and Professionalism. Hagerstown, MD; University Publishing Group 2005
• 67 Pink G H, McKillop I, Schraa E G et al.. Creating a balanced scorecard for a hospital system.  J Health Care Finance. 2001;  27 1-20
• 68 Zelman W N, Pink G H, Matthias C B. Use of the balanced scorecard in health care.  J Health Care Finance. 2003;  29 1-16
• 69 Zelman W N, Blazer D, Gower J M, Bumgarner P O, Cancilla L M. Issues for academic health centers to consider before implementing a balanced-scorecard effort.  Acad Med. 1999;  74 1269-1277
• 70 Clark P A. Can organizational ethics programs influence management initiatives?.  Organizational Ethics: Healthcare, Business, and Policy. 2005;  2 59-71
• 71 Biro L A, Moreland M E, Cowgill D E. Achieving excellence in veterans healthcare: a balanced scorecard approach.  J Healthc Qual. 2003;  25 33-39
• 72 Meliones J N, Ballard R, Liekweg R, Burton W. No mission-no margin: it's that simple.  J Health Care Finance. 2001;  27 21-29
• 73 Meliones J. Saving money, saving lives.  Harv Bus Rev. 2000;  78 57-62
• 74 Rimar S, Garstka S J. The “balanced scorecard”: development and implementation in an academic clinical department.  Acad Med. 1999;  74 114-122
• 75 Zbinden A M. Introducing a balanced scorecard management system in a university anesthesiology department.  Anesth Analg. 2002;  95 1731-1738
• 76 Chang A C. How to start and sustain a successful pediatric cardiac intensive care program: a combined clinical and administrative strategy.  Pediatr Crit Care Med. 2002;  3 107-111
• 77 Rimar S. Strategic planning and the balanced scorecard for faculty practice plans.  Acad Med. 2000;  75 1186-1188
• 78 Mills A E, Chen D T, Werhane P H, Wynia M K. Professionalism in Tomorrow's Healthcare System: Towards Fulfilling the ACGME Requirements for and Systems-Based Practice and Professionalism. Hagerstown, MD; University Publishing Group 2005
• 79 Berwick D M. Crossing the boundary: changing mental models in the service of improvement.  Int J Qual Health Care. 1998;  10 435-441
• 80 Berwick D M. A user's manual for the iom's “quality chasm” report.  Health Aff (Millwood). 2002;  21 80-90
• 81 Hahn D L. Physician opportunity costs for performing practice-based research.  J Fam Pract. 2000;  49 983-984
• 82 Chen D T. Curricular approaches to research ethics training for psychiatric investigators.  Psychopharmacology (Berl). 2003;  171 112-119